Yield10 Bioscience Stock Target Price and Analyst Consensus

YTEN Stock  USD 0.23  0.03  11.54%   
The current analyst and expert consensus on Yield10 Bioscience is Hold, with no strong buy opinions. The current projected Yield10 Bioscience target price consensus is 2.83 with 2 analyst opinions. The most common way Yield10 Bioscience analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Yield10 Bioscience executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Yield10 Bioscience. We encourage you to use your own analysis of Yield10 Bioscience to validate this buy or sell advice. Yield10 Bioscience buy-or-sell recommendation module provides average expert sentiment on the projected Yield10 Bioscience target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Yield10 Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
Lowest Forecast
2.58
Highest Forecast
3.14
Target Price
2.83
As of the 25th of April 2024, Gross Profit is likely to drop to about (241.5 K). In addition to that, Pretax Profit Margin is likely to grow to -228.87. At this time, Yield10 Bioscience's Short Term Debt is very stable compared to the past year. As of the 25th of April 2024, Common Stock is likely to grow to about 185.2 K, while Total Assets are likely to drop about 3.7 M.
  
It's important to approach Yield10 Bioscience's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Yield10 Bioscience price targets

Yield10 Bioscience's stock target price is an estimate of its future price, usually made by analysts. Using Yield10 Bioscience's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Yield10 Bioscience's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Yield10 Bioscience's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Yield10 Bioscience Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Yield10 Bioscience is a key component of Yield10 Bioscience valuation and have some predictive power on the future returns of a Yield10 Bioscience.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Yield10 Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.2216.03
Details
Intrinsic
Valuation
LowRealHigh
0.040.8816.69
Details
Naive
Forecast
LowNextHigh
00.2216.02
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.23-0.19-0.15
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Yield10 Bioscience. Your research has to be compared to or analyzed against Yield10 Bioscience's peers to derive any actionable benefits. When done correctly, Yield10 Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Yield10 Bioscience.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested over 100 shares
Dividend Beast Idea
Dividend Beast
Invested over 60 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 40 shares
Investor Favorites Idea
Investor Favorites
Invested over 40 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 40 shares
When determining whether Yield10 Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Yield10 Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Yield10 Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Yield10 Bioscience Stock:
Check out Macroaxis Advice on Yield10 Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.
Note that the Yield10 Bioscience information on this page should be used as a complementary analysis to other Yield10 Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Yield10 Stock analysis

When running Yield10 Bioscience's price analysis, check to measure Yield10 Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yield10 Bioscience is operating at the current time. Most of Yield10 Bioscience's value examination focuses on studying past and present price action to predict the probability of Yield10 Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yield10 Bioscience's price. Additionally, you may evaluate how the addition of Yield10 Bioscience to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
The data published in Yield10 Bioscience's official financial statements usually reflect Yield10 Bioscience's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Yield10 Bioscience. For example, before you start analyzing numbers published by Yield10 accountants, it's critical to develop an understanding of what Yield10 Bioscience's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Yield10 Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Yield10 Bioscience's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Yield10 Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Yield10 Bioscience. Please utilize our Beneish M Score to check the likelihood of Yield10 Bioscience's management manipulating its earnings.